What to expect from GPvP inspections
The GPvP webpage has recently been updated to provide additional information about the current inspection process. This post provides some further information about GPvP inspectors and inspections.
Compliance matters
The Responsible Person named on the WDA- Part 3: Expectations for the engagement of consultants as contract RPs
Posted by:
Madeleine Ault and Peter Brown, Posted on:
-
Categories:
Compliance matters, Good distribution practice
This is the final of three posts centered around the Responsible Person named on a Wholesale Distribution Authorisation (WDA) and covers the engagement of a contract RP
Process Licensing Office joins the Inspectorate
Posted by:
Mark Birse, Posted on:
-
Categories:
Compliance matters, Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice, Inside the Inspectorate
The Process Licensing Office has today joined the Inspectorate to become the Inspectorate & Process Licensing Group.
Sponsor Oversight- Part 1
The first of two posts focusing on sponsor oversight and how to improve compliance in this area.
The Responsible Person named on the WDA -Part 2: Effective Appointment and Training
This is the second in a set of three posts centred around the Responsible Person named on a Wholesale Distribution Authorisation (WDA). This post has been written to enhance the appointment of the RP.
MHRA Pharmacovigilance Symposium 2018
Posted by:
Mandeep Rai, Posted on:
-
Categories:
Compliance matters, Events and symposia, Good pharmacovigilance practice
In may, the GPvP Inspectorate held their symposium, which provided a platform for information sharing and discussion between inspectors and assessors from the MHRA and industry colleagues working within pharmacovigilance and associated departments.
The Responsible Person named on the WDA. Part 1: Raising the profile of the RP
Posted by:
Madeleine Ault and Peter Brown, Posted on:
-
Categories:
Compliance matters, Good distribution practice
This is the first in a set of three posts centered around the RP named on a WDA. This post provides information on external training recognition and training providers. The second of these three posts aim to enhance the appointment of the RP and the third post will place a particular emphasis on the engagement of a contract/consultant RP.
GCP Symposium 2018
Posted by:
Mandy Budwal-Jagait, Posted on:
-
Categories:
Compliance matters, Events and symposia, Good clinical practice
Find out how to register for the 2018 GCP Symposium.
I don't believe it!
Guidance and examples of data integrity issues seen on GDP inspections.
Obtaining medicines for wholesale using prescriptions and an important update on attempted thefts from warehouses
The GDP inspectorate has seen a growing number of false NHS and private prescriptions being used to obtain medicines from Marketing Authorisation Holders for the onward wholesale.
Related content and links
